On October 25, Gelonhui announced its third quarter report. In the first three quarters of 2024, beijing leadman biochemistry achieved revenue of 0.282 billion yuan, a decrease of 17.15% year-on-year; net income attributable to shareholders of the listed company was 1.0716 million yuan, a decrease of 95.49% year-on-year; net loss after deducting non-recurring gains and losses was 6.5087 million yuan, a decrease of 130.05% year-on-year; basic earnings per share were 0.0020 yuan/share.
利德曼(300289.SZ)：前三季度净利润107.16万元，同比下降95.49%
Beijing Leadman Biochemistry (300289.SZ): The net income in the first three quarters was 1.0716 million yuan, a year-on-year decrease of 95.49%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated